Carisma Therapeutics, Inc.
USD0.01
-0.00 (-27.16%)
CEO
Craig R. Jalbert
IPO Date
2014-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.00
52W High
$0.56
Market Cap
$0.00B
Volume
0.01M
| -1.1 |
| 31 Dec 2022 | FY | 100.0% | -622.6% | 39.0% | -84.9% | -0.26 | 2.78 | -8.0 |
| 31 Dec 2021 | FY | 99.7% | -1.3% | -0.2% | -0.1% | 0.00 | 17.77 | -442.2 |
| 31 Dec 2020 | FY | 100.0% | -252.3% | 307.2% | -15.0% | 0.00 | 3.48 | -5.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 402.6% | -94.0% | 0.00 | 6.39 | -0.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -76.2% | -30.2% | 0.00 | 8.47 | -2.6 |
| 31 Dec 2017 | FY | 100.0% | -6830.4% | -161.0% | -38.7% | 0.00 | 3.17 | -0.7 |
| 31 Dec 2016 | FY | 100.0% | 6.3% | 4.9% | 1.8% | 0.00 | 6.51 | 21.3 |
| 31 Dec 2015 | FY | 100.0% | -3379.0% | -176.6% | -90.8% | 0.73 | 4.79 | -1.7 |
| -0.4 |
| 31 Mar 2025 | Q1 | 100.0% | -248.5% | 25.3% | -58.1% | -0.06 | 1.34 | -0.3 |
| 31 Dec 2024 | Q4 | 81.7% | -482.8% | 63.2% | -57.9% | -0.09 | 1.48 | -0.2 |
| 30 Sept 2024 | Q3 | 100.0% | -375.2% | 114.2% | -30.2% | -0.30 | 3.23 | -0.8 |
| 30 Jun 2024 | Q2 | -66.4% | -121.4% | -3100.6% | -18.8% | 10.44 | 3.25 | -1.6 |
| 31 Mar 2024 | Q1 | -414.0% | -558.7% | -174.2% | -25.7% | 0.69 | 4.64 | -1.1 |
| 31 Dec 2023 | Q4 | 51.4% | -488.6% | -79.0% | -23.4% | 0.12 | 5.06 | -1.4 |
| 30 Sept 2023 | Q3 | -410.9% | -559.3% | -46.2% | -20.0% | 0.06 | 7.53 | -2.0 |
| 30 Jun 2023 | Q2 | -420.2% | -558.3% | -29.8% | -14.9% | 0.08 | 6.80 | -4.4 |